|
the Paradigm® REAL-Time System has
now arrived!
Component Overview
View the major components and their functionality (Requires Macromedia Flash Player).
The MiniMed Paradigm 522 or 722 insulin pump and the optional REAL-Time continuous glucose monitoring components are sold separately.
Demonstration
Play this video (Requires Macromedia Flash Player) to see how the system empowers "Caroline" to understand her blood sugar levels and make better, more confident self-management decisions throughout her day.
This demonstration is not for instructional purposes.
The Minimed Paradigm REAL-Time
system is the first system in the
world to integrate advanced insulin
pump therapy with continuous glucose
monitoring. It provides all the
benefits of Paradigm pump therapy
including improved control and
flexibility for your busy life.
Plus it gives you the information
you need to take action to control
your glucose levels, prevent highs
and lows, and protect yourself
against long-term
complications—insights that
fingersticks alone and A1C just
can’t deliver.
The new MiniMed Paradigm®
REAL-Time System features:
REAL-Time glucose readings
updated every five minutes, 24 hours
a day—up to 288 times a day—give you
REAL-Time information so you can
take REAL-Time action to reduce the
severity and duration of highs and
lows.1-4 You can view
your glucose levels on screen right
away at work or school, during
meals, and when exercising, and take
action right away.
REAL-Time alarms
warn you of highs and lows day and
night that fingersticks alone and
A1C testing may not reveal. Preset
alarms to sound or vibrate, and
adjust the sensitivity to your
liking.
REAL-Time trend arrows
show you the direction and degree of
change in glucose trends—important
since even brief changes can affect
the development of long-term
diabetes complications including
eye, nerve, kidney, and heart
disease.5
REAL-Time trend graphs
show you the effects of meals,
exercise, insulin, and medication on
your glucose levels. You can view
3-hour and 24-hour trend graphs on
screen.
1. Bode BW, et al. Diabetes
Research and Clin Practice.1999;46:183-90.
2. Kaufman FR, et al.
DiabetesCare. 2001;24(12):2030.
3. Ludvigsson J, et al.
Pediatrics.
2003;111(5 Pt 1):933-8.
4. Bode B, et al.
Diabetes Technol Ther.2004;6(2):105-13.
5. DCCT/EDIC Study Research Group.
N Engl J Med.
2005;353(25):2643-53
|